You prescribe Mounjaro to a new patient. They pay for month one. They come back for a dose review at week four. Then you never hear from them again.
They did not stop the medication. They just reordered from someone else. Someone whose system made it easier to come back.
That patient was worth £1,200 to £2,400 over 6 to 12 months. You captured one month. The rest went to a competitor who understood that GLP-1 is not a single appointment. It is a programme, and programmes need systems.
Table of Contents
- Why GLP-1 is not a one-off service
- What a 12-month patient is actually worth
- Where patients drop off and why
- The programme structure that keeps patients in
- Automating the touchpoints without losing clinical oversight
- How recurring revenue changes your business model
- What this looks like at scale
Why GLP-1 is not a one-off service
A patient starting Mounjaro begins on 2.5mg and titrates up over several months. The typical pathway runs through four to six dose levels, each lasting four weeks, before reaching the maintenance dose. Total treatment duration for most patients is 6 to 12 months at minimum, with many continuing beyond a year.
Each month requires a medication supply. Most months require some form of clinical check-in to assess tolerability, side effects, and weight response. Dose adjustments happen at defined intervals based on clinical criteria.
This is not a treatment where the patient attends once and the clinical relationship ends. It is a recurring programme with a natural monthly cadence, built-in clinical touchpoints, and a medication supply that needs replenishing every 28 days.
If your systems treat this like a single booking, you are structurally misaligned with how the treatment actually works. And every month you fail to recapture that patient is revenue walking to the clinic that makes reordering frictionless.
What a 12-month patient is actually worth
The economics of GLP-1 programmes become clear when you calculate lifetime value rather than single-appointment value.
A typical Mounjaro programme charges between £150 and £250 per month depending on dose level, whether you supply the medication or the patient sources it via a pharmacy, and whether the check-in is included or charged separately.
At £180 per month over 12 months, a single patient generates £2,160 in total revenue. Your acquisition cost for that patient was somewhere between £40 and £150 depending on your channel. That means your return on acquisition is between 14x and 54x, but only if you retain the patient for the full programme.
If they leave after month two, your return drops to £360 against a £40 to £150 acquisition cost. Still positive, but nowhere close to the economics that make weight loss clinics genuinely profitable.
The difference between a weight loss clinic that grows and one that struggles is rarely the number of new patients. It is the number of months each patient stays.
Where patients drop off and why
Patient attrition in GLP-1 programmes follows a predictable pattern. Understanding where the drop-off happens tells you exactly where to intervene.
Month 1 to 2: the friction gap
The highest drop-off point is between month one and month two. The patient finished their first supply. They need to reorder. If reordering requires them to call during opening hours, re-complete a full consultation, or navigate an unclear process, a significant percentage will delay. Delay turns into lapse. Lapse turns into loss.
The fix is structural: make month-two reordering as simple as confirming nothing has changed and paying. One tap, not one phone call.
Month 3 to 4: the plateau
Many patients experience a weight-loss plateau around months three and four as their body adjusts to the medication. Without proactive communication, the patient assumes the treatment has stopped working. They stop ordering.
A structured check-in at this stage, explaining that plateaus are expected and that dose adjustment is the next step, prevents a clinical reality from becoming a business loss.
Month 6 and beyond: silent drift
Patients who have been on the programme for six months sometimes stop ordering without any clear reason. They did not have a bad experience. They did not consciously decide to stop. They just forgot, got busy, or found the process of reordering slightly too much effort on a particular day.
Automated reminders sent 3 to 5 days before their supply runs out eliminate silent drift. The patient does not need to remember. The system remembers for them.
The programme structure that keeps patients in
A GLP-1 programme that retains patients for 6 to 12 months has a defined structure. It is not loose follow-up. It is a pathway with specific touchpoints, each one designed to keep the patient engaged and clinically safe.
Initial assessment and prescribing
BMI screening, contraindication check, medical history, informed consent. The patient is prescribed their starting dose and given clear expectations about the first four weeks.
Monthly clinical check-in
A short structured form capturing current weight, side effects, adherence, and any new medications. If nothing has changed, the reorder proceeds automatically. If something flags, it routes to the prescriber.
Dose escalation reviews
At each titration point, the prescriber reviews the patient's response and makes a dose adjustment decision. This is the moment of highest clinical value and should feel like genuine care, not a rubber stamp.
Maintenance phase
Once at target dose, the check-ins can extend to every 8 to 12 weeks rather than monthly. But medication supply remains monthly, and the reorder system must accommodate this rhythm without requiring a full clinical review each time.
Programme completion or de-escalation
When the patient reaches their target weight or decides to stop, a structured off-boarding captures their outcome data, books a final review, and schedules a follow-up check at 3 and 6 months post-treatment.
Every stage in this pathway is a retention mechanism. Skip any of them and you create a gap where the patient can silently disappear.
Automating the touchpoints without losing clinical oversight
The concern most prescribers raise about systematising GLP-1 programmes is that automation will compromise clinical safety. The reality is the opposite. A structured system is safer than an unstructured one.
What should be automated
- Reorder reminders sent at day 24 of each 28-day cycle
- Monthly check-in forms sent automatically with a link to the patient's pre-filled portal
- Flagging of clinical exceptions based on check-in responses
- Confirmation and payment processing for routine reorders
- Progress tracking visible to both patient and clinician
What should always require a prescriber
- Dose escalation decisions
- Patients reporting new side effects or medication changes
- Patients whose weight has not responded as expected after two consecutive months
- Any response on the monthly check-in that triggers a clinical flag
The distinction is clear. Routine continuation of an unchanged prescription with an unchanged clinical picture is an operational task. Clinical decision-making at inflection points is a prescriber task. A well-designed system handles the first automatically and escalates the second reliably.
This is safer than a manual process where every patient sits in the same queue regardless of clinical need, and where a busy prescriber may rubber-stamp a routine reorder with less attention than a system-flagged exception would receive.
How recurring revenue changes your business model
A weight loss clinic built on one-off appointments has a revenue model that resets to zero every month. Every pound of revenue next month depends entirely on next month's marketing spend and new patient acquisition.
A weight loss clinic built on a programme model has a growing recurring base. Each new patient adds to a base that generates revenue for 6 to 12 months after the acquisition cost is paid.
Forecasting becomes possible
If you have 150 active patients with an average monthly value of £180 and an 85% monthly retention rate, you know that next month will generate approximately £22,950 from existing patients regardless of how many new patients you acquire. Add new patients on top and your growth becomes predictable.
Acquisition spend becomes an investment
When you know a new patient is worth £2,160 over 12 months rather than £180 for a single appointment, your acceptable cost per acquisition changes dramatically. You can afford to spend £100 to £150 to acquire a patient who will generate £2,000+ in lifetime revenue. Clinics selling single appointments cannot compete at that acquisition cost.
Cash flow stabilises
A recurring revenue base smooths the peaks and troughs that make clinic finances stressful. January is no longer your only good month. Revenue compounds month over month as new patients layer on top of retained ones.
Clinic valuation increases
A business with predictable recurring revenue is worth significantly more than one with transactional revenue of the same total amount. If you ever consider selling your clinic, or taking on investment to expand, a demonstrable recurring patient base is the single most valuable asset you can show.
What this looks like at scale
A weight loss clinic acquiring 30 new patients per month, retaining at 85% monthly, and charging £180 per month builds like this:
- Month 1: 30 patients, £5,400
- Month 3: 30 new + 47 returning, £13,860
- Month 6: 30 new + 93 returning, £22,140
- Month 12: 30 new + 139 returning, £30,420
By month 12, recurring revenue from retained patients is generating five times the revenue of new patients alone. Same marketing spend. Same acquisition effort. The difference is entirely in retention systems.
The clinic that treats GLP-1 like a single appointment sees £5,400 per month, every month, forever. The clinic that treats it like a programme sees £30,000 per month within a year from the same starting point.
That is the recurring revenue model hidden inside your programme. It is already there. The only question is whether your systems are capturing it or letting it walk out the door every month.
Stop selling appointments and start building a programme
You already have the clinical pathway. You already have the patients. The missing piece is a system that captures the recurring revenue your programme naturally generates.
Book a free 20-minute discovery call and we will show you how the programme model works for your weight loss clinic, your patient volumes, and your current retention numbers.
